Registrations for the 2026 CSL RAI are now open.
CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organisations and companies.

• Up to USD $400,000 funding over 2 years
• CSL scientific champion assigned to each project
• Focused on early-stage projects
• Simple and fast 300-word initial application
• Clear and transparent timelines
• Open to research organisations (universities, medical research institutes, hospitals) and companies (start-ups, biotechs)